IP Library Granted Patent US 9,781,919
Granted Patent B2
US 9,781,919 · App. 14/997,933 · Granted Oct 10, 2017

Compositions and methods for improving the quality of processed sperm

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,781,919
App. No.
14/997,933
Granted
Oct 10, 2017
Kind
B2
Abstract

The present invention generally relates to compositions and methods for the handling of processed sperm populations including samples that are freshly collected, those transported as fresh samples, as well as samples that are frozen and thawed, those sorted into one or more subpopulations, and those that are otherwise processed or handled that impose trauma on the sperm cell. Such trauma can reduce the motility, fertility, viability and overall integrity of the sperm and reduce the sperm's ability to fertilize an egg, grow into a health embryo and produce a healthy offspring. The present invention relates to novel compounds that can be added to the sperm cell sample to reduce the traumatic effects of physical stress during mild as well as extensive sperm cell processing, methods of using the compounds in standard sperm processing procedures, the end products made from these methods including sperm and embryos, as well as methods of using those end products in assisted reproductive biology techniques in animals.

Claims (7)

1. A sperm cell composition comprising a sperm cell sample and vitamin B12, or a vitamin B12 vitamer, at a concentration of 0.01 mg/ml to 1 mg/ml.

2. The sperm cell composition of claim 1 , further comprising alpha ketoglutarate at a concentration of 0.01 mg/ml to 5 mg/ml.

3. The sperm cell composition of claim 2 , wherein the concentration of the added alpha ketoglutarate is selected from the group consisting of: 0.01 to 5.0 mg/ml; 0.01 to 0.25 mg/ml; 0.01 to 0.5 mg/ml; 0.01 to 1 mg/ml; 0.01 to 2.5 mg/ml; 0.01 to 5 mg/ml; 0.05 to 0.1 mg/ml; 0.05 to 1.0 mg/ml; 0.05 to 2.5 mg/ml; 0.1 to 0.25 mg/ml; 0.1 to 0.5 mg/ml; 0.1 to 1 mg/ml; 0.1 to 2.5 mg/ml; 0.1 to 5 mg/ml; 0.15 to 0.45 mg/ml; 0.15 to 0.5 mg/ml; 0.25 to 0.35 mg/ml; 0.25 to 0.5 mg/ml; 0.25 to 1 mg/ml; 0.25 to 2.5 mg/ml; 0.25 to 5 mg/ml; 0.35 to 0.5 mg/ml; 0.35 to 1 mg/ml; 0.35 to 2.5 mg/ml; 0.35 to 5 mg/ml; 0.5 to 1 mg/ml; 0.5 to 2.5 mg/ml; 0.5 to 5 mg/ml; 1 to 2.5 mg/ml; and 1 to 5 mg/ml.

4. The sperm cell composition of claim 2 , wherein the concentration of the vitamin B12, or vitamin B12 vitamer, or alpha ketoglutarate, is selected from the group consisting of: 0.05 mg/ml; 0.1 mg/ml; 0.15 mg/ml; 0.25 mg/ml; 0.35 mg/ml; 0.45 mg/ml; and 0.5 mg/ml.

5. The sperm cell composition of claim 2 , wherein the concentration of the vitamin B12, or vitamin B12 vitamer, or alpha ketoglutarate, is selected from the group consisting of: 0.15 mg/ml; 0.25 mg/ml; and 0.35 mg/ml.

6. The sperm cell composition of claim 2 , wherein the sperm cell composition is cryopreserved.

7. The sperm cell composition of claim 2 , wherein the sperm cell sample is derived from a human, bovine, swine, ovine, equine, deer, elk, buffalo, canine, feline, chimpanzee or gorilla, or whale, dolphin or other marine mammal.

Assignments (3)
SECURITY INTEREST Recorded Nov 24, 2025
From: INGURAN, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 073783/0924 →
SECURITY INTEREST Recorded Mar 31, 2021
From: INGURAN, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055791/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2016
From: LENZ, RICHARD; MORENO, JUAN; VISHWANATH, RAMAKRISHNAN
To: INGURAN, LLC
Reel/Frame 037836/0202 →